Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the "real world"

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Kotz, Daniel ^a,b   Brown, Jamie ^b   West, Robert ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Behavioural support; Nicotine replacement therapy; Prospective cohort study; Smoking cessation; Varenicline

Indexed keywords

BENZAZEPINE DERIVATIVE; NICOTINE; NICOTINIC AGENT; QUINOXALINE DERIVATIVE; VARENICLINE;

ADOLESCENT; ADULT; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NETHERLANDS; PATIENT COMPLIANCE; PROCEDURES; PROSPECTIVE STUDY; QUESTIONNAIRE; SMOKING CESSATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BENZAZEPINES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; NICOTINE; NICOTINIC AGONISTS; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; QUINOXALINES; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 84935010456     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-1163     Document Type: Article

References (20)

1. Cahill K, Stevens S, Perera R, Lancaster T: Pharmacological interventions for smoking cessation: An overview and network meta-analysis. Cochrane Database Syst Rev 2013, (5). Retrieved from http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009329.pub2/abstract doi:10.1002/14651858. CD009329.pub2.
2. Biazzo LL, Froshaug DB, Harwell TS, Beck HN, Haugland C, Campbell SL, Helgerson SD: Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy. Nicotine Tobacco Res 2010, 12(6):567-573. doi:10.1093/ntr/ntq045.
3. Brose L, West R, Stapleton J: Comparison of the effectiveness of varenicline and combination nicotine replacement therapy for smoking cessation in clinical practice. Mayo Clin Proc 2013, 88(3):226-233.
4. Brose LS, West R, McDermott MS, Fidler JA, Croghan E, McEwen A: What makes for an effective stop-smoking service? Thorax 2011, 66(10):924-926. doi:10.1136/thoraxjnl-2011-200251.
5. Dhelaria RK, Friderici J, Wu K, Gupta E, Khan C, Rothberg MB: Effectiveness of varenicline for smoking cessation at 2 urban academic health centers. European J Int Med 2012, 23(5):461-464.
6. Kralikova E, Kmetova A, Stepankova L, Zvolska K, Davis R, West R: Fifty-twoweek continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy. Addiction 2013, 108(8):1497-1502. doi:10.1111/add.12219.
7. Sicras Mainar A, Navarro Artieda R, Diaz Cerezo S, Marti Sanchez B, Sanz De Burgoa V: Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care. Aten Primaria 2011, 43(9):482-489. doi:10.1016/j.aprim.2010.09.010.
8. Stapleton JA, Watson L, Spirling LI, Smith R, Milbrandt A, Ratcliffe M, Sutherland G: Varenicline in the routine treatment of tobacco dependence: A pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction 2008, 103(1):146-154.
9. Steinberg MB, Bover MT, Richardson DL, Schmelzer AC, Williams JM, Foulds J: Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies. Drug Alcohol Depend 2011, 114(1):77-81. doi:10.1016/j.drugalcdep.2010.06.022.
10. Kotz D, Brown J, West R: Effectiveness of varenicline versus nicotine replacement therapy for smoking cessation with minimal professional support: Evidence from an English population study. Psychopharmacology 2014, 231(1):37-42. doi:10.1007/s00213-013-3202-x.
11. Fidler JA, Shahab L, West R: Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerstrom Test for Nicotine Dependence and its components. Addiction 2011, 106(3):631-638. doi:10.1111/j.1360-0443.2010.03226.x.
12. Kotz D, Brown J, West R: 'Real-world' effectiveness of smoking cessation treatments: A population study. Addiction 2014, 109(3):491-499. doi:10.1111/add.12429.
13. Fidler J, Shahab L, West O, Jarvis M, McEwen A, Stapleton J, West R: 'The Smoking Toolkit Study': A national study of smoking and smoking cessation in England. BMC Public Health 2011, 11(1):479.
14. The Smoking Toolkit Study: Retrieved 16 April 2011, from www.smokinginengland.info.
15. West R, Zatonski W, Przewozniak K, Jarvis MJ: Can we trust national smoking prevalence figures? Discrepancies between biochemically assessed and self-reported smoking rates in three countries. Cancer Epidemiol Biomarkers Prev 2007, 16(4):820-822.
16. Wong SL, Shields M, Leatherdale S, Malaison E, Hammond D: Assessment of validity of self-reported smoking status. Health Rep 2012, 23(1):47-53.
17. Aubin HJ, Bobak A, Britton JR, Oncken C, Billing CB Jr, Gong J, Reeves KR: Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax 2008, 63(8):717-724. doi:10.1136/thx.2007.090647.
18. Taggar J, Coleman T, Lewis S, Szatkowski L: The impact of the quality and outcomes framework (QOF) on the recording of smoking targets in primary care medical records: cross-sectional analyses from the health improvement network (THIN) database. BMC Public Health 2012, 12(1):329.
19. Lawrence D, Mitrou F, Zubrick SR: Non-specific psychological distress, smoking status and smoking cessation: United States national health interview survey 2005. BMC Public Health 2011, 11:256. doi:10.1186/1471-2458-11-256.
20. Kotz D, Fidler J, West R: Very low rate and light smokers: smoking patterns and cessation-related behaviour in England, 2006-2011. Addiction 2012, 107(5):995-1002. doi:10.1111/j.1360-0443.2011.03739.x.